The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Open accessAbstract
Cancer cells are hallmarked by high proliferation and imbalanced redox consumption and signaling. Various oncogenic pathways such as proliferation and evading cell death converge on redox-dependent signaling processes. Nrf2 is a key regulator in these redox-dependent events and operates in cytoprotection, drug metabolism and malignant progression in cancer cells. Here, we show that patients with primary malignant brain tumors (glioblastomas, WHO °IV gliomas, GBM) have a devastating outcome and overall reduced survival when Nrf2 levels are upregulated. Nrf2 overexpression or Keap1 knockdown in glioma cells accelerate proliferation and oncogenic transformation. Further, activation of the Nrf2-Keap1 signaling upregulates xCT (aka SLC7A11 or system X c−) and amplifies glutamate secretion thereby impacting on the tumor microenvironment. Moreover, both fostered Nrf2 expression and conversely Keap1 inhibition promote resistance to ferroptosis. Altogether, the Nrf2-Keap1 pathway operates as a switch for malignancy in gliomas promoting cell proliferation and resistance to cell death processes such as ferroptosis. Our data demonstrate that the Nrf2-Keap1 pathway is critical for cancer cell growth and operates on xCT. Nrf2 presents the Achilles’ heel of cancer cells and thus provides a valid therapeutic target for sensitizing cancer for chemotherapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,086
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
Rac Downregulates Rho Activity
Sander, E. E., ten Klooster, J. P., van Delft, S., van der Kammen, R. A., & Collard, J. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.1009 · Cited by 831
Ui-Tei, K. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh247 · Cited by 808
Chan, K., Lu, R., Chang, J. C., & Kan, Y. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13943 · Cited by 645
LAU, A., VILLENEUVE, N., SUN, Z., WONG, P., & ZHANG, D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.003 · Cited by 645
Glutamate release by primary brain tumors induces epileptic activity
Buckingham, S. C., Campbell, S. L., Haas, B. R., Montana, V., Robel, S., Ogunrinu, T., & Sontheimer, H. (2011) · Nature Medicine · doi:10.1038/nm.2453 · Cited by 578
Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., Tamba, M., Itoh, K., Yamamoto, M., & Bannai, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208704200 · Cited by 542
Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M., & Hirohashi, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.082 · Cited by 468
Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
Homma, S., Ishii, Y., Morishima, Y., Yamadori, T., Matsuno, Y., Haraguchi, N., Kikuchi, N., Satoh, H., Sakamoto, T., Hizawa, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2822 · Cited by 418
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Lee, D.-F., Kuo, H.-P., Liu, M., Chou, C.-K., Xia, W., Du, Y., Shen, J., Chen, C.-T., Huo, L., Hsu, M.-C., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.025 · Cited by 399
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
Kim, Y. R., Oh, J. E., Kim, M. S., Kang, M. R., Park, S. W., Han, J. Y., Eom, H. S., Yoo, N. J., & Lee, S. H. (2010) · The Journal of Pathology · doi:10.1002/path.2653 · Cited by 358
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
Lister, A., Nedjadi, T., Kitteringham, N. R., Campbell, F., Costello, E., Lloyd, B., Copple, I. M., Williams, S., Owen, A., Neoptolemos, J. P., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-37 · Cited by 242
Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Ohyama, C., & Itoh, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00221-14 · Cited by 208
Oncogenic functions of the transcription factor Nrf2
Gañán-Gómez, I., Wei, Y., Yang, H., Boyano-Adánez, M. C., & García-Manero, G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.041 · Cited by 202
Overexpression of Heme Oxygenase-1 in Murine Melanoma
Was, H., Cichon, T., Smolarczyk, R., Rudnicka, D., Stopa, M., Chevalier, C., Leger, J. J., Lackowska, B., Grochot, A., Bojkowska, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051365 · Cited by 192
Savaskan, N. E., Heckel, A., Hahnen, E., Engelhorn, T., Doerfler, A., Ganslandt, O., Nimsky, C., Buchfelder, M., & Eyüpoglu, I. Y. (2008) · Nature Medicine · doi:10.1038/nm1772 · Cited by 192
Self-citationLu, K., Alcivar, A. L., Ma, J., Foo, T. K., Zywea, S., Mahdi, A., Huo, Y., Kensler, T. W., Gatza, M. L., & Xia, B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2204 · Cited by 181
Lewerenz, J., Albrecht, P., Tien, M. T., Henke, N., Karumbayaram, S., Kornblum, H. I., Wiedau‐Pazos, M., Schubert, D., Maher, P., & Methner, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06347.x · Cited by 175
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic
O’Connell, M. A., & Hayes, J. D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150069 · Cited by 162
Reddy, N. M., Kleeberger, S. R., Bream, J. H., Fallon, P. G., Kensler, T. W., Yamamoto, M. P., & Reddy, S. P. (2008) · Oncogene · doi:10.1038/onc.2008.188 · Cited by 145
IKEDA, H., NISHI, S., & SAKAI, M. (2004) · Biochemical Journal · doi:10.1042/bj20031948 · Cited by 136
Sehm, T., Fan, Z., Ghoochani, A., Rauh, M., Engelhorn, T., Minakaki, G., Dörfler, A., Klucken, J., Buchfelder, M., Eyüpoglu, I. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8651 · Cited by 134
Self-citationRen, J., He, W., Nong, L., Zhu, Q., Hu, K., Zhang, R., Huang, L., Zhu, F., & Wu, G. (2010) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0701 · Cited by 123
To “Grow” or “Go”: TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN
Shiwarski, D. J., Shao, C., Bill, A., Kim, J., Xiao, D., Bertrand, C. A., Seethala, R. S., Sano, D., Myers, J. N., Ha, P. K., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0363 · Cited by 105
Ma, X., Zhang, J., Liu, S., Huang, Y., Chen, B., & Wang, D. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1722-9 · Cited by 89
The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas
Chen, D., Rauh, M., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2017) · Oncotarget · doi:10.18632/oncotarget.17737 · Cited by 72
Self-citationZhang, J., Park, S. I., Artime, M. C., Summy, J. M., Shah, A. N., Bomser, J. A., Dorfleutner, A., Flynn, D. C., & Gallick, G. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30710 · Cited by 60
Roh, J., Kim, E. H., Jang, H.-J., & Shin, D. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.002 · Cited by 55
The involvement of Nrf2–ARE pathway in regulation of apoptosis in human glioblastoma cell U251
Pan, H., Wang, H., Zhu, L., Wang, X., Cong, Z., Sun, K., & Fan, Y. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000094 · Cited by 54
Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line
Zhou, Y., Wang, H., Zhu, L., Cong, Z., Li, N., Ji, X., Pan, H., WANG, J.-W., & Li, W. (2012) · Oncology Reports · doi:10.3892/or.2012.2115 · Cited by 50
Ji, X., CHEN, S.-H., Zhu, L., Pan, H., Zhou, Y., Li, W., You, W., Gao, C.-C., Zhu, J., Jiang, K., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2476 · Cited by 47
xCT modulation in gliomas: Relevance to energy metabolism and tumor microenvironment normalization
Savaskan, N. E., & Eyüpoglu, I. Y. (2010) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2010.07.003 · Cited by 41
Self-citationThe Effects of Nrf2 on Tumor Angiogenesis: A Review of the Possible Mechanisms of Action
Zhou, S., Ye, W., Zhang, M., & Liang, J. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i2.60 · Cited by 40
Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Savaskan, N. E., Fan, Z., Broggini, T., Buchfelder, M., & Eyüpoglu, I. Y. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150122224158 · Cited by 39
Self-citationClinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma
Chen, J., Yu, Y.-J., Ji, T., Ma, R., Chen, M., Li, G.-F., Li, F.-B., Ding, Q., Kang, Q., Huang, D.-Y., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.788 · Cited by 34
Tong, Y., Zhang, B., Yan, Y., Fan, Y., Yu, J., Kong, S., Zhang, D., Fang, L., Su, D., & Lin, N.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.17403 · Cited by 32
PRG3 induces Ras-dependent oncogenic cooperation in gliomas
Fan, Z., Bittermann-Rummel, P., Yakubov, E., Chen, D., Broggini, T., Sehm, T., Majernik, G. H., Hock, S. W., Schwarz, M. A., Engelhorn, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8592 · Cited by 12
Self-citation
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435
Ferroptosis: machinery and regulation
Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1810918 · Cited by 2,099
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
The Metabolic Underpinnings of Ferroptosis
Zheng, J., & Conrad, M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.011 · Cited by 1,329
Metadata
- Authors
- Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N.
- Venue
- Oncogenesis
- Published
- 2017-08-14
- Volume
- 6
- Issue
- 8
- Pages
- e371-e371
- ISSN
- 2157-9024 (ISSN-L)
- OpenAlex
- W2745891591
- Cited by
- 692
- References
- 45
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.